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Behaviors observed at the cellular level such as development and acquisition of effector functions by immune
cells result from transcriptional changes. The biochemical mediators of transcription are sequence-specific
transcription factors (TFs), chromatin modifying enzymes, and chromatin, the complex of DNA and histone
proteins. Covalent modification of DNA and histones, also termed epigenetic modification, influences the
accessibility of target sequences for transcription factors on chromatin and the expression of linked genes
required for immune functions. Genome-wide techniques such as ChIP-Seq have described the entire
‘‘cistrome’’ of transcription factors involved in specific developmental steps of B and T cells and started to
define specific immune responses in terms of the binding profiles of critical effectors and epigenetic modifi-
cation patterns. Current data suggest that both promoters and enhancers are prepared for action at different
stages of activation by epigenetic modification through distinct transcription factors in different cells.Introduction
There are numerous types of cells that comprise the immune
system and many mechanisms that these cells use to rid the
body of foreign invaders. In order to manipulate the immune
response, it is necessary to understand the basic biochemical
effectors of immunity. Recently, genome-scale measurements
of transcription factor binding and histone modification in
lymphocytes have extended our understanding of chromatin-
based processes such as transcription, transcription factor
binding, and histone modification, and synthesis of this data
has led to an outline of genetic circuits that control immune func-
tion.
All genetic information is carried in the sequence of the DNA,
but the complex of DNA and histone proteins, called chromatin,
modulates interpretation of the sequence. The basic repeat unit
of chromatin, the nucleosome, is formed by wrapping DNA
around a histone octamer comprised of two copies of the histone
proteins H2a, H2b, H3, and H4. Covalent modifications of DNA
and histones influence the molecular processes that use chro-
matin as a substrate. In particular, it is well established that
DNA methylation is involved in transcriptional repression, while
post-translational modification on histones can be either acti-
vating or repressive to transcription depending on the nature
and position of a particular modification. The location of nucleo-
somes along DNA also regulates the accessibility of critical cis-
regulatory sequences (i.e., promoters and enhancers) to trans-
regulatory transcription factors and has important roles in
immune function.
Previous studies have identifiedmany DNA sequence-specific
transcription factors that are required for the development and
effector functions of B and T lymphocytes. Although many
targets for each factor have been identified, it is necessary to
identify all its target genes and the regulatory elements that
mediate its function in order to comprehensively understand
how each factor functions and how they interact and influence
each other in the genome. Binding sites are typically identified830 Immunity 34, June 24, 2011 ª2011 Elsevier Inc.by Chromatin immunoprecipitation (ChIP) followed by poly-
merase chain reaction (ChIP-PCR), however application of
microarray (ChIP-chip) or next generation high throughput DNA
sequencing (ChIP-Seq) makes it possible to enumerate target
sites genome-wide. Because of advantages in cost, sensitivity,
and speed, ChIP-Seq is the most versatile and only genome-
scale technique for genomes larger than yeast or fly. In this
review, we will first introduce recent progress in ChIP-Seq and
related techniques, and discuss the application of these tech-
niques to important immunological questions, emphasizing
lymphocyte biology.
ChIP-Seq and Related Techniques
Both histone modification and transcription factor binding can
be measured by the ChIP assay. The assay requires first
crosslinking of chromatin to stabilize the interaction between
protein factors and chromatin. Because histone-DNA contacts
are very stable, histone modification can be measured with
either crosslinked or native chromatin. For achieving high reso-
lution, chromatin is broken tomononucleosome-sized fragments
by sonication or micrococcal nuclease (MNase) digestion.
Because MNase preferentially degrades nucleosome linker
DNA, it results in uniform mononucleosome-sized fragments
and higher resolution of histone modifications. Sonication is the
preferred method of chromatin fragmentation for mapping
target sites of transcription factors so that their binding sites,
which are often located in the linker regions are not digested.
Specific histone modifications or transcription factors are
precipitated with antibodies and then DNA associated with
the precipitated material is isolated. For identification of all
target sites, the ChIP DNA is sequenced to saturation with
next-generation sequencing techniques (ChIP-Seq) (Schones
and Zhao, 2008), which provides sufficient sequencing depth
to recover all target sites and provides a quantitative measure-
ment of target distribution in the genome (Jothi et al., 2008;
Zang et al., 2009; Zhang et al., 2008).
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the procedure. Although the assay usually requires 1 to 10million
cells, recent progress has optimized ChIP conditions to signifi-
cantly decrease starting cell number. So far this small-cell tech-
nique is limited to histone modifications and has not been
reported for transcription factor binding (Adli et al., 2010).
For determiningwhich regions of the genome are enriched and
relate them to other known functional elements (i.e., other TF
binding sites or genes), the short sequence reads (tags) gener-
ated are aligned to the reference genome. After conversion of
the sequence data to position data, these short sequences are
analyzed with various peak-calling algorithms to identify the
ChIP-enriched regions as target sites of histone modifications
or transcription factor binding. Although it is possible to visually
identify or call binding sites from Genome Browser displays,
application of peak finding algorithms allows identification of
all sites and permits statistical analysis of a binding event.
Different algorithms are appropriate depending on the specific
factor being analyzed. Several algorithms including MACS
(Zhang et al., 2008) and SISSRs (Jothi et al., 2008) work well
for identification of tightly localized signals such as transcription
factor binding sites, H3K4me3, H3K9ac, etc. Other algorithms,
SICER (Zang et al., 2009) or ChromaBlocks (Hawkins et al.,
2010), were specifically designed for identifying chromatin
domains of diffuse signals spread over a large genomic region
such as H3K27 methylation and H4K16ac.
Another difficult, but key issue for ChIP-Seq is the selection of
proper controls for ChIP-Seq data analysis. The most common
choices for control libraries are immunoprecipitates with total
IgG or pre-enriched chromatin (input) used for ChIP. Most
nonspecific IgG preparations are usually not truly preimmune
IgGs (from the same animal before immunization) and don’t
control for the nonspecific and cross-reactivity of the affinity-
purified antibody. Furthermore, nonspecific IgGs usually pull
down very little DNA and often lead to biased PCR amplification
of sequences at only limited genomic loci. Consequently, this
does not provide a good background model of the genome.
For this reason, the chromatin input is a better control because
it generates an accurate estimation of biases that are introduced
in ChIP assays as a result of sonication of chromatin and
sequencing.
These technical caveats may be seen as trivial, but the size of
genomewide data sets greatly increases the possibilities of false
positives. Local differences in chromatin cause different sonica-
tion efficiencies, and a ChIP library will be enriched for these
regions over unrelated and silent chromatin regions. Active
functional regions of the genome can be identified by their sensi-
tivity to sonication just as they are sensitive to DNase (Teytelman
et al., 2009). In addition, there are many data analysis steps
between the raw data and the binary call of ‘‘bound’’ or
‘‘unbound.’’ Because of unfamiliarity and technical separation
from these steps experimental biologists may be led to false
conclusions.
DNA methylation, which mainly occurs within 50-cytosine-
guanine-30 dinucleotides (CpGs) in mammals, is perhaps the
best understood epigenetic mechanism implicated in transcrip-
tional repression. Methylated cytosine (MeC) can be detected by
modification with sodium bisulfite, MeC binding proteins
(methyl-binding domains [MBDs]), or antibodies against MeC.Bisulfite conversion-based methods provide single-base-pair
resolution. Unfortunately, the scale needed to achieve meaning-
ful coverage of amammalian genome limits its broad application.
So that the sequenced region is restricted, enrichment of
genomic regions associated with methylated DNA with an
antibody recognizing MeC (MeDIP) or MeC-binding proteins,
followed by sequencing of the enriched DNA (MeDIP-Seq),
provides a convenient and genome-wide strategy for detection
of DNA methylaton (Bock et al., 2010). Unfortunately, these
affinity-based approaches suffer from low resolution and the
bias that CpG-rich sequences are better enriched than equally
methylated but CpG-poor regions. Thus, they are suited to
compare the relative methylation levels of CpG-rich regions
under different conditions but not for the quantitative measure-
ment of each individual CpG base pair. Because of continuous
decreases in cost and increases in sequencing capacity, it is
likely that bisulfite-conversion and sequencing will become
routine. Further technical advances allow direct measurement
of MeC, and new sequencing platforms with this capacity will
soon be available to the community (Flusberg et al., 2010).
The position and occupancy of nucleosomes can be deter-
mined by sequencing the ends of mononucleosome associated
DNA generated by micrococcal nuclease (MNase) (Schones
et al., 2008). Because MNase preferentially degrades linker
DNA, sequencing of the ends of DNA fragments generated by
MNase digestion provides nucleosome position information.
One issue for mapping nucleosome distribution is whether the
chromatin should be crosslinked with formaldehyde before
MNase digestion. In general, crosslinking is not required given
that the nucleosome structure is relatively stable under the
MNase-Seq conditions and the results with or without prior
crosslinking are fairly similar (K. Cui, personal communication).
In some cases, crosslinking may further stabilize fragile nucleo-
somes at promoter and enhancer regions. Unfortunately, cross-
linking with HCHO may also stabilize non-nucleosome protein
complexes on chromatin, and protect DNA from the MNase
digestion. This can result in some protected regions not related
to nucleosome structure, complicating interpretation.
Traditionally, functional enhancers and promoters were pre-
dicted by the presence of DNase I hypersensitive (HS) sites on
Southern blot assays. Application of the next generation seq-
uencing technique to detect the DNase I HS sites reveal the
genome-wide distribution of HS and their association with
histone modifications (Boyle et al., 2008). These data are ex-
tremely valuable as a gold standard for enhancer identification.
Similarly, the accessibility of chromatin to restriction enzymes
has been combined with next generation sequencing (NA-Seq),
providing an alternative method to monitor genome-wide the
status of chromatin during differentiation of immune cells (Gar-
giulo et al., 2009).
General Features of T Cell Epigenomes
Themost comprehensively characterizedepigenome isof human
CD4+ T cells, with data of genome-wide distribution of more than
20 histone methylation, 18 histone acetylation, histone variant
H2A.Z, nucleosome positions, RNA polymerases II and III, and
various transcription factors and cofactors (Barski et al., 2010;
Barski et al., 2007; Schones et al., 2008;Wanget al., 2008). These
data sets confirmed and extend previous observations thatImmunity 34, June 24, 2011 ª2011 Elsevier Inc. 831
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correlated with gene activation. H3K27me2, H3K27me3,
H3K9me2, H3K9me3, and H4K20me3 are exceptions that are
negatively correlated with gene expression. Furthermore, active
genes tend to be associated with multiple ‘‘active’’ modifications,
whereas silent genes are associated with only a few ‘‘repressive’’
modifications or are not associated with any modification.
Thegeneral correlation between histonemodification andgene
activity had already been established, but the length of modifica-
tion islands is best observed by studying genome-widemodifica-
tion patterns. This provides insight into themechanisms of depo-
sition of a given posttranslational modification (PTM). For
example, H3K27me3 marks are spread broadly over repressed
genes because of the self-propagation of this mark that is added
and recognized by distinct subunits of the polycomb repressor
complexes (Xu et al., 2010). H3K4me3, associated with active
promoters, is highly localized to a few nucleosomes around
promoter regions, probably deposited by complexes that directly
interact with sequence specific factors. Other activating modifi-
cations, H3K4me1, for example, are also broadly spread at
many genomic regions (Barski et al., 2007), but the mechanisms
that give rise to these large islands are not known.
Different functional genomic regions are associated with
distinct sets of histone modifications. The transcribed regions
of active genes are usually associated with histone H4 acetyla-
tion, monomethylation of H2BK5, H3K9, H3K27, H4K20, and
H3K36me3, and mono-, di-, or trimethylation of H3K79. Active
promoters are enriched with multiple modifications including
H3K4me1, H3K4me2, H3K4me3, H3K9ac, and histone variant
H2A.Z. More than 25% of all promoters are associated with
a common set of 17 modifications in addition to other modifica-
tions (Wang et al., 2008). Transcriptional enhancers, defined as
regions of DNA that activate transcription but are not located
at the transcriptional start site (TSS), are marked by histone
modifications such as H3K4me1 (Heintzman et al., 2009).
Although H3K4me1 is detected at most enhancers, it is not the
best mark to pinpoint functional enhancer elements because of
its broad distribution in the genome. In contrast, H3K4me2,
H3K9ac, H3K27ac, and H3K18ac are better markers of en-
hancers because of their sharp signals (Creyghton et al., 2010;
He et al., 2010; Rada-Iglesias et al., 2011; Roh et al., 2007;
Wang et al., 2008). p300, the histone acetyltransferase (HAT)
that acetylates H3 on K18 and 27, is also a good enhancer
marker (Jin et al., 2011; Visel et al., 2009). Differential marking
of enhancers by H3K27me3 or H3K27acmay indicate alternative
status of enhancer activity as demonstrated in embryonic stem
cells (ESCs) (Rada-Iglesias et al., 2011).
In addition to histone modification, histone position is also
dynamically regulated. Active genes with elongating PolII and
genes with paused PolII exhibited several highly positioned
and phased nucleosomes relative to their TSSs (Schones
et al., 2008). These results suggest that a nucleosome at the
transcription initiation site is not compatible with PolII binding
and has to be relocated to allow binding of PolII. Accordingly,
there is no characteristic nucleosome pattern in genes when
they are not associated with PolII. Enhancer function also
involves nucleosome reorganization that is regulated by T cell
receptor (TCR) signaling (Schones et al., 2008). Because the
nucleosome structure is generally inhibitory to binding of tran-832 Immunity 34, June 24, 2011 ª2011 Elsevier Inc.scription factors, enhancer nucleosomes are reorganized such
that target motifs are located in the linker region (He et al.,
2010). This feature has been successfully used for identification
of functional enhancers.
Changes in Epigenetic Markings Are Observed during
Differentiation, Cytokine Expression, and
Transdifferentiation of Helper T Cells
Naive CD4+ T cells can be differentiated into different T helper
cells including Th1, Th2, and Th17 cells characterized by expres-
sion of specific cytokines and transcription factors. Several
studies characterized the epigenetic pattern associated with
these genes in T helper lineages (Agarwal and Rao, 1998; Akimz-
hanov et al., 2008; Avni et al., 2002; Chen et al., 2005; Fields
et al., 2004; Hatton et al., 2006; Santangelo et al., 2002; Schoen-
born et al., 2007). A genome-wide data set for H3K4me3 and
H3K27me3 in naive, Treg, and T helper cells demonstrates that
the signature cytokine gene loci are associated with the epige-
netic modification corresponding to their expression pattern.
The Th1-specific Ifng gene (coding the cytokine interferon-g) is
associated with H3K4me3 in Th1 cells andH3K27me3 in all other
cells, whereas the Th2 cell-specific Il4 gene (coding the cytokine
interleukin 4) is associated with H3K4me3 only in Th2 cells and
H3K27me3 in other cells, consistent with these cells being
epigenetically stable lineages (Wei et al., 2009).
In contrast to these expected patterns, key transcription
factors required for Th cell differentiation have different patterns
of modification. The Tbx21 gene, which encodes T-bet, a key
transcription factor for Th1 cell differentiation, is associated
with both H3K4me3 and H3K27me3 in naive cells. After differen-
tiation, the promoter resolves to only H3K4me3 in Th1 cells,
consistent with its active expression, whereas it remains associ-
ated with both H3K4me3 and H3K27me3 in other Th cells.
The coexistence of H3K4me3 andH3K27me3, termed bivalent
modification, was proposed to play critical roles unique to ESC
differentiation (Bernstein et al., 2006); however, it exists at a large
number of genes in adult tissue and is probably a general mech-
anism to keep genes in a silent, but inducible state (Cui et al.,
2009; Mohn et al., 2008; Roh et al., 2006). T helper cells are
considered terminally differentiated cells, but the unresolved
bivalency at the promoters of key transcription factor genes in
the nonexpressing cells suggested that their expression can be
induced under appropriate conditions, leading to alternate cell
fate. Indeed, the expression of Tbx21 is induced in natural T
regulatory cells under Th1 cell culture conditions, which is corre-
lated with expression of IFN-g, suggesting that the cells can
assume a Th1 cell fate. The fate of Th17 cells can also be
changed during late development (Lee et al., 2009), which is
attributed to the epigenetic instability of the IL-17 locus (Mukasa
et al., 2010). These results collectively support the model that
monovalent modification (H3K4me3 alone for an active locus
or H3K27me3 alone for an inactive locus) confers epigenetic
and phenotypic stability. The opposite of this, epigenetic indeci-
sion (lack of anymodification or both active and repressivemodi-
fications at inactive locus) allows T helper cell plasticity.
How does bivalent modification prime genes for induction in
response to TCR or differentiation signals? Histone methylation
provides recognition signals for various cofactors of transcrip-
tion and thereby modulates transcription. H3K27me3 is added
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Figure 1. Epigenetic Memories of Different Activation Stages of Promoters and Enhancers
The upper panel shows the different status of promoter activation indicated with different colors below the cartoon. The distinguishing epigenetic modifications
associated with the promoter status and classes of genes that exhibit the epigenetic pattern in particular lineages or cell activation states are also indicated. The
lower panel shows the different status of enhancer activation and the associated epigenetic modification with each status. The bound transcription factors and
cofactors associated with each status are also indicated.
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complex and recognized by the PRC1 repressive complex that
maintains a repressive chromatin environment for transcription
(Margueron and Reinberg, 2011). The function of H3K4me3 in
regulating gene activation is mediated by a number of mecha-
nisms. First, it interacts with ATP-dependent chromatin remod-
eling complexes Chd1 and NURF (Pray-Grant et al., 2005;
Wysocka et al., 2006), which open chromatin to allow binding
of other transcription regulators. Second, H3K4me3 signals
mediate binding of the NuA3 histone acetyltransferase (Martin
et al., 2006). Third, the MLL and hSET1 complexes, which are
responsible for adding the H3K4 methylation mark, are associ-
ated with the MOF acetylase (Dou et al., 2005; Wysocka et al.,
2005) and Sin3 deacetylase (Wysocka et al., 2003), respectively.
These data suggest that H3K4 methylation modulates the
histone acetylation status of a gene by recruiting HATs and
histone deacetylases (HDACs). Indeed, promoters marked by
H3K27me3 alone are not be acetylated even in the presence of
HDAC inhibitors, but bivalent promoters are rapidly acetylated
by HDAC inhibitor treatment (Wang et al., 2009). Inhibition of
WDR5, an essential subunit of the MLL complexes that are
responsible for H3K4me3, compromise the histone acetylation
induced by HDAC inhibitors. These results support the model
that H3K4 methylation facilitates the dynamic cycle of acetyla-
tion and deacetylation by transient binding of HATs and HDACs
at bivalent promoters. This maintains a silent state, but at thesame time primes them for induction in response to appropriate
environmental cues (Wang et al., 2009).
The epigeneticmarks associated with gene promoters that are
turned on very quickly after a stimulus are nearly identical to that
of active genes, and little if any epigenetic change is associated
with these genes during a short-term expression change. There-
fore, active histone modifications provide a chromatin environ-
ment to support ongoing transcription and to poise genes for
rapid induction after a stimulus (Figure 1, top panel). Among
genes induced in human resting CD4+ T cell by T cell receptor
signaling after 18 hr, most are associated with prior H3K4 meth-
ylation, H2A.Z, and PolII, and very little H3K27me3; this pattern
does not change much during the course of gene induction
(Barski et al., 2009). In contrast, developmental genes are primed
by the active mark, H3K4 methylation, and the repressive mark,
H3K27me3; additionally, they are associated with only very low
levels of histone acetylation and PolII. Thus, activation of these
genes is much slower than that of the fully poised genes.
Establishment of new histone modification patterns is ob-
served at cytokine genes after extended TCR signaling (Araki
et al., 2009; Aune et al., 2009), which is the result of the differen-
tiation process associated with the extended TCR signaling.
Cytokine genes in quiescent memory cells are associated with
this signal-dependent poised promoter configuration. Examples
of this are the Ifng gene in resting Th1 cells and Il4 gene in resting
Th2 cells. Both so can be rapidly transcribed upon antigenImmunity 34, June 24, 2011 ª2011 Elsevier Inc. 833
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configuration at key cytokine and effector genes forms the basis
of immune memory (Barski et al., 2009).
Analogous to promoters, enhancers are associated with
distinct epigenetic modification patterns when they are silent,
active, or poised (Figure 1, bottom panel). Silent enhancers are
associated with H3K27me3 and no active modification. Much
like the case of promoters, enhancers are often developmentally
poised with histone methylation marks; poised enhancers may
also have H3K4me1 and H3K27me3 when they are inactive,
but remain accessible. Signal-dependent poised enhancers
are marked by H3K4me1-2, which have lost the silencing marks,
but remain inactive. Full activity is regulated by histone acetyla-
tion and is acutely induced at binding sites of inducible transcrip-
tion factors and deposited by p300 (Ghisletti et al., 2010).
Accordingly the correlation between enhancer activity and
p300 or H3K27ac, the mark deposited by p300, is high; both
p300 binding and H3K27ac have been successfully used as
signals to predict functional enhancers (Creyghton et al., 2010).
Modulation of the acetylation status is a critical step for initiating
and terminating enhancer activity.
Prevention of DNAmethylation is another mechanism to prime
enhancer activity. For example, DNA in the enhancer of the
T cell-specific ptcra gene must be demethylated at the earliest
stages of development, with machinery that is only present in
ESCs. If methylated transgenes are introduced to T cell lines,
the transgene is not demethylated, the enhancer doesn’t acquire
active histone modifications, and finally the cells are no longer
able to express this gene. In contrast, if the transgene is not
methylated, or if it is introduced to ESCs, where demethylation
occurs, full activity is observed (Xu et al., 2007; Xu et al., 2009).
This mechanism of enhancer preparation will be more difficult
to explore at a global level, but it is important to consider.
The ‘‘Average’’ Epigenome
The general arrangement and features of epigenomes of are the
same in all tissues that have been measured including ESCs,
hematopoietic stem cells, neurons, and T cells. From the epige-
netic perspective, all genes and enhancers conform to the same
pattern of histone modifications and can be classified to a small
number of states: silent, developmentally or signal dependent-
poised, or active. The correlation between these states and func-
tional activity is so high that a statistical analysis of histone
modifications can identify genes, enhancers, repeat elements,
silent chromatin, or other functional elements without prior
knowledge of the genome (Ernst and Kellis, 2010). Each state
is defined by the presence of several histone modifications
that always coexist, as is the case with a core set of 17 modifica-
tions previously detected at promoters (Wang et al., 2008).
The functional relevance of havingmany histonemodifications
together is difficult to know. Histone-modifying enzymes typi-
cally exist in large multiprotein complexes that contain several
enzymatic subunits and therefore may simply travel together,
and inmany cases themarkmay not have a function. More likely,
different modifications have different functions and work
together in an additive or collaborative fashion to maintain a fully
active configuration of chromatin. Still another possibility is that
different active modifications function redundantly in order to
maintain a robust chromatin structure. In this case, an occa-834 Immunity 34, June 24, 2011 ª2011 Elsevier Inc.sional absence of one modification will not have deleterious
effects on the chromatin structure. In addition to the interlocus
comparison of different modification patterns, inhibition of
enzymes that are responsible for the modification, either by
SiRNA mediated reduction in protein levels in vitro or targeted
deletion in animals, can provide valuable information on the func-
tion of a modification. Direct mechanistic insight may be derived
from experiments using chemically synthesized and modified
chromatin as has recently been proposed, but these are beyond
our current technical abilities (Allis and Muir, 2011).
As noted above, established histone modification patterns
self-propagate, but changes in epigenetic patterns are mediated
by sequence-specific transcription factors. One of the best-
studied examples is the Cd4 enhancer that is required to estab-
lish epigenetic patterns during development but becomes
dispensable in mature cells (Chong et al., 2010). Sequence-
specific transcription factors bind to enhancers and recruit
epigenetic enzymes to effect their gene expression changes.
Below, we focus on the transcription factors that mediate
T helper cell differentiation and B cell commitment. These are
chosen because they are paradigms for rapid induction of
gene expression after extracellular signaling in the case of
T cells, the B cell transcriptional cascade is well known, and
currently both systems have been well studied by genome-
wide techniques.
Identification of Direct Target Genes of Key
Transcription Factors during T Helper Cell
Differentiation
Because of the different life cycles of pathogens such as viruses,
extracellular bacteria, or parasites, different clearing mecha-
nisms must be employed. The immune system has several
distinct batteries of immune effectors that are suited for different
pathogens so that Th1 cells are tuned toward viruses and
promote cell lysis, whereas Th2 cell responses are more appro-
priate to clear extracellular pathogens and lead to humoral
responses. Th17 and Treg cells are implicated in controlling
inflammation and suppressive function, respectively. Key tran-
scription factors regulating these various Th cells have been
well characterized. Tbx21, coding T-bet, is required for the Th1
cell fate (Afkarian et al., 2002; Kaplan et al., 1996b; Szabo
et al., 2000; Thierfelder et al., 1996), and GATA3 is essential for
the Th2 cell differentiation (Kaplan et al., 1996a; Takeda et al.,
1996; Zheng and Flavell, 1997). Th17 cell commitment requires
the TGF-b signaling pathway and a key transcription factor,
RORgt (Chen et al., 2006; Dong, 2008; Korn et al., 2007; Nurieva
et al., 2007; Wei et al., 2007; Yang et al., 2008; Zhou et al., 2007).
Foxp3 is a key transcription factor required for Treg cell differen-
tiation and function (Elias et al., 2008; Lohr et al., 2006; Miyara
and Sakaguchi, 2007; Zheng and Rudensky, 2007).
Various members of the signal transducer and activator of
transcription proteins (STATs) function to either enhance or
inhibit T helper cell differentiation and function (Adamson et al.,
2009). STAT4 and STAT6 reciprocally regulate the differentiation
of Th1 and Th2 cells, respectively. In response to cytokine
signaling including IL-12 and IL-23, STAT4 directly activates
the expression of the Th1 cell cytokine IFN-g (Thierfelder et al.,
1996) and indirectly regulates the Th1 cell transcription factor
T-bet via the kinase MAP3K8 through a positive feedback loop
Immunity
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activating the Il4r gene and is required for expression of the Th2
cell transcription factor GATA3 (Kurata et al., 1999; Liao et al.,
2008; Zheng and Flavell, 1997). In other contexts, STAT5
promotes Treg cell differentiation by directly binding to the
Foxp3 promoter and activating its expression (Burchill et al.,
2007). Meanwhile, STAT3 is a positive regulator of Th17 cell
differentiation by directly or indirectly activating the Rorc gene
that encodes RORgt (Laurence et al., 2007).
STAT proteins also act as negative regulators of alternative T
helper fates. For example, STAT5 inhibits Th17 cell differentia-
tion (Laurence et al., 2007), whereas STAT3 inhibits Foxp3
expression (Zhou et al., 2007). In other contexts, STAT3 physi-
cally interacts with Foxp3 and is required for the immunosup-
pressive function of Treg cells (Chaudhry et al., 2009). Mean-
while, STAT6, which is critically required for Th2 cells, also
inhibits Foxp3 expression (Takaki et al., 2008).
Numerous genes are known to be affected by deletion of these
key transcription factors in various Th cells. However, in order to
gain full understanding of the global regulatory networks
controlled by these factors, all targets must be determined.
Although a few studies have been published on identification
of Foxp3 and GATA3 targets with DNA microarrays
(Jenner et al., 2009; Yagi et al., 2010; Zheng et al., 2007), more
genome-wide studies have focused on various STATs as
reviewed below.
Wei et al. (2010) identified genome-wide target sites of
STAT4 under Th1 cell conditions and target sites of STAT6
under Th2 cell conditions. Approximately 4000 genes were
bound by each transcription factor in these cells; and 63%
of the binding occurred in intergenic regions and 31% localized
to promoters. Approximately 50% of the STAT4 and STAT6
target genes overlapped. A smaller set of genes (508) was
found bound by STAT6 in another study (Elo et al., 2010), which
identified the primary and secondary direct target genes during
a time course experiment. Recent data indicate that STAT5 is
also critically involved in the differentiation of Th2 cells by regu-
lating the expression of Il4r. STAT5 becomes bound to its target
sites at the beginning of Th2 cell differentiation and the binding
is sustained or enhanced after two rounds of Th2 cell polariza-
tion at many critical target genes (Liao et al., 2008). Comparison
of the STAT5 and STAT6 target genes reveal a statistically
significant overlap (Elo et al., 2010), suggesting a similar target-
ing mechanism. These data demonstrate that STAT5, STAT4,
and STAT6 have broad effects in Th1 and Th2 cell differentia-
tion and provide a comprehensive view of their target genes
and potential function in T helper cells. Despite the well-estab-
lished function of STAT proteins as activators of transcription,
these genome-wide studies identified hundreds of genes that
are directly repressed by STAT binding. Interestingly, these
factors bind to a subset of Th1 cell- and Th2 cell-specific genes
and act in an opposing manner to modulate epigenetic modifi-
cations and gene expression (Wei et al., 2010). However, it is
not clear how STAT proteins mediate transcriptional repression
of target genes and oppose the function of the other STATs.
One possibility is that these STATs, which recognize similar
binding motifs, could compete for the same binding sites and
recruit different cofactors for either transcriptional activation
or repression.The balance of Th17 and Treg cells is critical for host immunity,
which is reciprocally regulated by STAT5 and STAT3. With
a colitis model, a recent study showed that STAT3 has an essen-
tial role in driving both colitis and systemic inflammation by
promoting Th17 cell differentiation and inhibiting Treg cell con-
version. Among the 3000 genes bound by STAT3, as identified
by ChIP-Seq, are most of the genes known to be involved in
Th17 cell differentiation (Durant et al., 2010). After stimulation
of CD4+ T cells with IL-21, STAT3 binds its target sites, and the
majority overlapped with the binding sites of IRF4. Interestingly,
deletion of IRF4 resulted in a global loss of STAT3 binding as
compared to the wild-type cells (Kwon et al., 2009). The depen-
dence of STAT3 binding to target sites on the presence of IRF4 is
consistent with a critical role of IRF4 in the development of
inflammatory Th17 cells (Bru¨stle et al., 2007).
Characterization of Global Regulatory Networks
in B Cell Development
The transcriptional regulatory network critical for B cell develop-
ment has been extensively studied. The self-reinforcing, core set
of transcription factors that limit alternative lineage potential and
specify the B cell fate is the sequentially expressed E2A, EBF1,
and Pax5 proteins (Ramı´rez et al., 2010). In brief, E2A expression
is induced as cells enter the lymphoid lineages and restricts
erythroid and myeloid potential. Evidence for this includes
single-cell cultures of E2A-deleted cells (Dias et al., 2008) and
an E2A-deficient progenitor cell line. Although this cell line
resembles and has the growth requirements of a population of
cells that is normally B cell restricted, it maintains multilineage
potential (Ikawa et al., 2004). E2A collaborates with PU.1,
another important transcriptional regulator, in several hemato-
poietic lineages. The IL-7R is an important target of Pu.1 at this
stage (DeKoter et al., 2002). A combination of E2A, Pu.1, and
Stat5 induce expression of EBF1 in early B cell progenitors
(Roessler et al., 2007).
Within the blood lineages, EBF1 expression is limited to B
cells, and a central role of EBF1 in B cell development is high-
lighted by its ability to bypass developmental blocks caused
by loss of PU.1 or E2A (Medina et al., 2004). An EBF1-deficient
B cell progenitor line that maintains multilineage potential has
also been created (Pongubala et al., 2008).
Much B cell work focused on the transcription factor Pax5
because of the surprising discovery that Pax5-deficient
pro-B cells, ordinarily B lineage committed, maintain alternative
lineage potential (Nutt et al., 1999). Furthermore, induced dele-
tion of Pax5 in mature B cells reconfers multilineage potential
(Cobaleda et al., 2007). Other transcription factors including
GABPa (Xue et al., 2007), Ikaros (Reynaud et al., 2008), and
Gfi1b (Ramı´rez et al., 2010; Spooner et al., 2009) have critical
roles in B cell lineage. Similar to critical factors in T cells, impor-
tant questions remain regarding how these factors are induced,
where the corresponding cis-regulatory elements appear, and
how they interact with each other to regulate the immune activity.
Recent analyses taking advantage of ChIP-Seq have provided
insights into these questions.
EBF1 binds to more than 9000 genomic regions in pro-B
cells (Treiber et al., 2010). Through use of cells with targeted
deletion of the Ebf1 gene or overexpression of EBF1 cDNA
together with the binding data, it was demonstrated that EBF1Immunity 34, June 24, 2011 ª2011 Elsevier Inc. 835
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tend to co-occur with motifs of several transcription factors
including Ets1 and E2A. In addition, EBF1 binds a large fraction
of genes that are regulated by Pax5. This argues that the core B
cell transcription factor activities are coupled by mutual positive
regulation and by binding the same sets of targets. Indeed,
another study has provided genome-wide evidence that E2A
binding sites significantly overlap with the binding sites of
EBF1 or Foxo1 (Lin et al., 2010). Interestingly, compound hetero-
zygosity for EBF1 and E2A, the factors that bind the most
enriched DNA sequence motifs for a set of E2A binding sites,
causes a cooperative block in B cell development (O’Riordan
and Grosschedl, 1999).
On the basis of this previous work and the discovery that
Foxo1 and E2A characterized another set of E2A binding sites,
Foxo1 and E2A compound heterozygous mice were created.
These mice also generate very limited B cell numbers. Nearly
50% of the EBF1 binding sites in pro-B cells are flanked by an
E2A binding site, suggesting that E2A may bind collaboratively
by either interacting with EBF1 or preparing the chromatin for
access by EBF1. Induction of the E2A isoform E47 demonstrates
that it is capable of inducing H3K4me1 and also displacing
nucleosomes. This effect depends on the transactivation domain
of E2A. Lastly, using a mix of data regarding bound or differen-
tially expressed genes, the authors find a gene network that
illuminates the interactions of E2A, Foxo1, and EBF1 in the B
cell network (Lin et al., 2010).
Another key transcription factor required for B cell develop-
ment is Pu.1. Pu.1 is broadly expressed and important for nearly
every blood lineage, including hematopoietic stem cells (Iwasaki
et al., 2005). ChIP-Seq analysis of Pu.1 binding in B cells and
macrophages reveal a large number of binding sites (32,000 to
45,000) (Heinz et al., 2010). Controlled expression of Pu.1
directly induces H3K4 methylation and nucleosome reorganiza-
tion at its binding sites in hematopoietic cells and also in 3T3
cells (Ghisletti et al., 2010), directing conversion of fibroblasts
to macrophages (Feng et al., 2008). These results suggest that
Pu.1 functions as a global genomic organizer by priming chro-
matin at regulatory regions for further downstream events in
cellular differentiation programs (Natoli, 2010). There is very little
overlap of Pu.1 binding sites between B cells and macrophages.
In each cell type the Pu.1 sites are colocalized with sequence
motifs corresponding to lineage-determining transcription
factors, suggesting an extensive collaboration between tran-
scription factors. Specifically, expression of E2A recruits Pu.1
to E2A/PU.1 shared binding sites in B cells, whereas C/EBPb
and Pu.1 cooperatively bind at a different set of sites in macro-
phages. Cooperative binding of these specific factors shapes
the cistromes of both, surely directing lineage commitment
(Heinz et al., 2010).
‘‘Average’’ Behavior of Transcription Factors
Several properties characteristic of all transcription factors have
been determined from genome-wide studies of transcription
factor binding: (1) most transcription factors bind to one primary
consensus motif that is conserved in all tissues; (2) binding is
context dependent and the same factor recognizes distinct cis-
tromes in different cells; (3) secondary motifs of tissue-specific
collaborating transcription factors distinguish cistromes of836 Immunity 34, June 24, 2011 ª2011 Elsevier Inc.a factor in different cells; (4) although binding events are typically
enriched near genes, most binding sites are located far away
(>10 kb) from known transcriptional start sites; (5) with loss or
gain-of-function experiments, transcription of only a minor frac-
tion of bound genes is influenced by the transcription factor; and
(6) networks of transcription factors are established by positive
and negative regulation of other critical regulators.
These properties reflect the typical analyses that are donewith
any ChIP-Seq data set. After calling binding sites, the top motifs
and associated secondary motifs are scored so that potential
collaborating factors in the genome can be predicted. It is impor-
tant to test the functional importance of the binding events, typi-
cally by loss or gain of function of the transcription factor. Unfor-
tunately, for ease of interpretation, the overlap of genes that are
bound and genes that are differentially regulated is poor often
5%–20%. This is significantly higher than expected by chance,
but it means that themajority of binding events are not functional
in that they do not immediately influence transcription.
There are several reasons why transcription factor binding is
poorly coordinated with transcriptional output. First, the local
bindingof a transcription factormay regulate other genes through
long-distance chromatin interaction. Visualization of direct inter-
action between enhancers and promoters by genome-wide 3C
assays will help to solve this problem. Second, transcription
factor binding may regulate the genes under various conditions
the cells may encounter in vivo but which are not operative
in vitro under the assay condition. Third, the primary role of a tran-
scription factor may be to induce histone modification at an
enhancer. Transcriptional activation of the target gene requires
additional factors. Thus, deletion of the bound factor from the
cells will not have apparent effect on the expression of the bound
gene at that time. At different stages, when other relevant factors
become present in the cell and the enhancer is active, loss of any
of these factors may influence transcription of the target gene.
Although demonstration of binding is not sufficient to say that
a transcription factor regulates a gene, it provides evidence
that the transcription factor may regulate the bound gene under
appropriate conditions.
In addition to the classic model where transcription factors
bind to promoters or enhancers and affect the levels of mRNA
for proximal protein coding genes, the number of binding sites
permits other functions. If a factor binds at greater than 30,000
genes, many of which are far from genes or in the middle of
genes, they may lead to transcription of microRNAs, other non-
coding RNA species, or previously unannotated genes. Intra-
genic binding may control alternative promoter usage or splicing
or ensure proper direction of transcription. It is fairly likely that
many sites have no function and result from the random occur-
rence of transcription factor binding motifs expected in seq-
uences as long as mammalian genomes. Whichever turns out
to be the case, the binding profiles generated by ChIP-Seq are
much more complex than could be predicted if transcription
factors only controlled the on or off state of a gene.
Interplay of Epigenetic Modifications and Transcription
Factors
ChIP-Seq analyses have revealed that the binding sites for most
transcription factors are in enhancers far from promoter regions.
Nucleosomes surrounding enhancers are marked by various
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variant H2A.Z, suggesting that the chromatin structure at
enhancers is prepared for binding of transcription factors when
they become available in response to cell surface signaling.
Indeed, previous studies have demonstrated that the inducible
transcription factors such as NFATs and STATs migrate to the
nucleus and become bound to chromatin a few minutes after
TCR and cytokine stimulations of T cells. The ChIP-Seq studies
also show that STATs and NF-kB bind to their target genes
quickly after cytokine and LPS treatments, respectively (Barish
et al., 2010; Liao et al., 2008). In particular, upon LPS stimulation,
p300 and NF-kB become bound to thousands of potential
enhancers that already display the H3K4me1 modification.
This indicates that their target sites have been prepared for rapid
binding of p300 and NF-kB upon signaling (Ghisletti et al., 2010).
The conclusion that cistromesofmany factors are regulated by
pre-existing histone modifications leads to the question of how
these marks are deposited. Current data suggest that pioneer
factors and cooperative binding of different factors direct binding
in a sequence-dependent and chromatin-independent manner.
Duringdifferentiationof hematopoietic stemcells to erythrocytes,
GATA1 functions as a pioneering factor by binding to nucleo-
somalDNAand recruits thebrahmaassociated factor (BAF) chro-
matin remodeling complexes (Kim et al., 2009) to remodel chro-
matin to allow accessibility of chromatin. Another member of
theGATA family transcription factors, GATA3, may have a similar
role during Th2 cell differentiation, given that it has been shown
that the essential subunit BRG1 of the BAF complexes is associ-
ated with several key Th2 cell cytokine enhancers that are known
GATA3 target sites. STAT6 may also be involved in recruiting
BRG1 to enhancers because deletion of STAT6 impaired its
recruitment to distal enhancers of the Gata3 gene (De et al.,
2011). Genetic targeting of Stat4 is correlated with globally
decreased H3K4me3 at STAT4 target promoters (Wei et al.,
2010), which suggests that STAT4 maintains the active
H3K4me3 mark by recruiting histone modifying enzymes.
In Th17 cells, IRF4 prepares chromatin for STAT5 binding
given that it constitutively binds to sites overlapping with
STAT5 sites and its deletion severely compromises the STAT5
binding after IL-21 treatment of CD4+ T cells (Kwon et al.,
2009). In B cells, E2A, EBF1, and Pax5 are all likely factors that
bind to their target sites during different stages of development
and modulate chromatin structure to prepare their target genes
for future action in response to environmental cues, and their
binding induced H3K4 methylation at numerous sites (Heinz
et al., 2010; Lin et al., 2010). In addition to establishing these
marks, continuous binding is required because inhibition of
Pu.1 in macrophage cells decreases H3K4me1 levels at its
binding sites (Ghisletti et al., 2010). Even though these factors
influence epigenomes, they still require a specific chromatin
environment or presence of collaborating factors for binding to
their target sites. For example, ectopically expressed B cell
factor EBF1 bound to its target gene Egr3 in a CD4+CD8+
T cell progenitor line but not in NIH 3T3 fibroblasts (Treiber
et al., 2010). Similarly, Pu.1 was associated with distinct cis-
tromes in B cells and macrophages, indicating the importance
of cellular context for its targeting (Heinz et al., 2010).
On the basis of all of these findings, it is obvious that histone
modifications influence transcription factor binding, which inturn influence further histone modification. All blood lineages
are derived from hematopoietic stem cells and similarly, all
T helper cells are derived from naive CD4+ T cells. Each cell
type is associated with a distinct epigenome that results from
the interaction of the progenitor epigenome and the transcription
factors in the cell. Differentiation is initiated by environmental
signals that trigger inducible transcription factors (Figure 2).
The inducible transcription factors collaborate with constitutive
transcription factors, bind to target sites situated in open chro-
matin, and subsequently activate transcription of the poised
target genes including other transcription factors and chromatin
modifiers. The newly expressed transcription factors could bind
to target sites with open chromatin and target sites without prior
active modifications and over time modulate chromatin modifi-
cation at novel sites for existing transcription factors. When the
resulting transcription factor program and epigenome stabilize,
the cell will wait until further environmental cues cause further
differentiation. This cycle will continue until the cell dies or rea-
ches a terminal differentiation state. This is defined as a cell
type that can give rise to no new cell types, but molecular
features based on epigenetics or transcription factor expression
has not been defined.
Perspective
Despite certain limitations, ChIP-Seq is a powerful technique for
characterization of status of chromatin and identification of
target sites of epigeneticmodification enzymes and transcription
factors. The data derived from these analyses are of high predic-
tive value for the potential of gene expression and comprehen-
sive identification of cis-regulatory elements of transcription
including enhancers and promoters. As the genome-wide data
for transcription factors and other enzymes become available,
combined with specific gene deletion, expression profiling,
protein-protein interaction, and genome-wide chromatin inter-
action studies, these data sets can be integrated to obtain
a comprehensive picture of how individual factors act and how
they cooperate in the development, differentiation, and function
of immune cells. In particular, this kind of analysis and data inte-
gration will aid us to address important questions of how basic
mechanisms manifest to determine cell fate; how bivalent modi-
fications at key transcription factors are established and main-
tained in nonexpressing lineages; and how the developmental
history of immune cells is remembered.
Most studies mentioned above seek to understand the regula-
tion of mRNA output of the nucleus because this causally
determines the effector function of the cell. Analysis of ChIP-
Seq data has focused on creating an average gene profile and
an average binding motif. This is appropriate for factors with
enzymatic activity. p300 binding, PRC binding, and resulting
histone modifications are excellent predictors of the functions
for underlying stretches of DNA. Histone modification profiles
and binding patterns of enzymes that write them can be pre-
sented as averages because they generally have one specific
biological effect. This is in contrast with sequence specific
transcription factors for which the effect of binding is nuanced
and locus specific.
If the average binding profile of a transcription factor is not
useful, it remains to be determined whether there are intuitive
and meaningful ways to integrate genome-wide binding setsImmunity 34, June 24, 2011 ª2011 Elsevier Inc. 837
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Figure 2. Signal-Dependent Transcription Factors Lead to Developmental Decisions by Sequentially Activating Epigenetically Distinct Sets
of Genes
Two different signals (A or B) activate, through pre-existing but signal-dependent transcription factors, shared gene set 2 and distinct gene set 1 or set 3, which
are poised by active chromatin marks. Transcription factors TfA or TfB are induced and resolve the marks at bivalent genes, set 4 or set 5, allowing for expression
of pioneer factors (TfpA or TfpB) that cause further epigenetic changes. The pioneer factors lead to epigenetic changes and induction of a new set, set 6 or set 7, of
genes, resulting in a cell primed for a different set of responses.
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sets have been used for determining genetic networks that
control developmental decisions, but these efforts are still some-
what difficult to grasp and limited by the measurement of the
input data sets. Because of the novelty of these techniques,
the first studies have focused on known master regulators, while
the features of less well characterized transcription factors
aren’t known. Hopefully, after more genome-wide profiles are
created, general features that distinguish master regulators or
oncogenes from less important or harmful transcription factors
will become clear.
Future mechanistic exploration will require the measurement
of transcription factor binding in live cells. Static models imply
large protein complexes nucleating around sequence-specific
factors. Current technologies are not sufficient, and ChIP is too
inefficient to determine the true nature of transcription at
single-cell or single-locus levels. Where it has been measured
it is clear that transcription factors do not have long residence
times on DNA (Stavreva et al., 2004). Histone modification may
be a form of ‘‘memory’’ of transcription factor binding that over-
comes the need to have all partner factors present at once. The
time that a locus is bound by any factor may be nearly as impor-838 Immunity 34, June 24, 2011 ª2011 Elsevier Inc.tant as which factors bind it. This mechanism of action could
explain probabilistic, binary enhancer activity (Walters et al.,
1995). The unlikely assembly of many components all required
for transcription may give rise to transcriptional bursts (Suter
et al., 2011).
In addition to the need for new methods to understand
genome-wide data collectively, it is important that genome-
wide data sets are supplied in ways that allow access to the
whole community, in particular to biologists who do not have
the technical ability to analyze ChIP-Seq data. It is a real possi-
bility that each binding event must be considered independently
given that the sequence of every promoter, enhancer, etc. is
unique. Because each sequence is bound independently, they
also function independently. Although there is a possibility that
a ChIP-Seq (or ChIP-PCR) signal for a transcription factor or
chromatin modifier at one genomic locus is not due to direct
binding of the factor at the locus but instead is generated by
crosslinking with another genomic locus through long-distance
interactions, the spatial proximity of the two genomic loci
suggests a possible functional link. Displaying ChIP-Seq data
on genome browsers provides useful information and allows
for ‘‘spot’’-checking and in silico ChIP ‘‘experiments.’’ This is
Immunity
Reviewappropriate, given that the correlation between ChIP-PCR and
ChIP-seq is high.
As we discussed above, the binding sites identified by ChIP-
Seq assays are subject to a number of complications including
variations in cell source, ChIP conditions, and control and
parameter choices in peak identification algorithms. All of these
can drastically affect the final definition of a cistrome associated
with a specific factor. Conditions must be standardized in order
to make meaningful comparisons between different cell types,
conditions, and results from different laboratories. It will be diffi-
cult to standardize everything, so it is also important to develop a
set of library statistics. These statistics will allow an outside ob-
server to quickly assess the quality of a data set. Useful param-
eters will probably include signal versus noise and saturation
estimates, but such standards have not been implemented.
The power and scope of the genome-wide data sets gener-
ated with ChIP-Seq and related techniques, in particular now
that they are combined with other technologies, such as mass
spectrometry, and manipulations, as in genetically-modified
mice, are changing the way of immunology research. Because
so many observations can be made in parallel, it is reasonable
to claim that high-quality data presents a complete picture of
the genome as observed by each transcription factor. The
main difficulty remaining is to establish novel, holistic paradigms
to understand andmanipulate the resulting immune phenomena.ACKNOWLEDGMENTS
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